“Placebo- Controlled Trial of Pharmaceutical Optimized Lisinopril 10mg (F-5) in Patients with Essential Hypertension for Efficacy & Biochemical Evaluation”, mfm, vol. 25, no. 12, Apr. 2024, Accessed: Feb. 01, 2026. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/2376